This medical device company develops a transcatheter tricuspid valve repair system designed to treat tricuspid regurgitation. Their implant aims to increase valve coaptation, offering physicians a low-profile and efficient solution for repairing the tricuspid valve.
Funding
Funding not disclosed
Founders
Product
Problem
Tricuspid regurgitation, a condition where the tricuspid valve doesn't close properly, leads to blood flowing backward into the heart. Current treatments often involve complex surgical procedures, and there is a need for less invasive and more efficient repair methods. Existing solutions may not fully address central and side leaks, potentially impacting long-term device performance.
Solution
Trilio Medical is developing a transcatheter tricuspid valve repair system designed to provide a simple and complete solution for tricuspid regurgitation. The system utilizes a low-profile design intended to empower physicians to easily repair the tricuspid valve. The implant's unique spacer shape aims to provide full coverage of both central and side leaks. The design builds on common practices to allow for a quick procedure and a short learning curve for physicians. Preservation of the native leaflets is a key design consideration, with the goal of prolonging device life expectancy.
Target Audience
The primary target audience includes interventional cardiologists and cardiac surgeons specializing in structural heart disease interventions.
Features
- Low-profile transcatheter delivery system for minimally invasive tricuspid valve repair.
- Unique spacer shape designed for complete coverage of central and side leaks.
- Designed to preserve native leaflets, potentially extending device life.
- Intended to reduce the risk of post-procedural bleeding.
- Designed to minimize X-ray exposure during the procedure.